We have located links that may give you full text access.
Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil.
Revista da Sociedade Brasileira de Medicina Tropical 2016 November
INTRODUCTION:: The aim of this study was to investigate the prevalence of Chagas disease in patients treated at a Public Oncology Service in the City of Pelotas, Southern Brazil.
METHODS:: This study included 200 individuals undergoing cancer treatment and involved the use of a questionnaire and venous blood collection for the detection of anti-Trypanosoma cruzi antibody.
RESULTS:: The study found a 5% prevalence of patient seropositivity. Significant variables are presented and discussed in the article.
CONCLUSIONS:: Serological T. cruzi checks are recommended in cancer patients, especially individuals from endemic areas in Brazil and other Latin American countries.
METHODS:: This study included 200 individuals undergoing cancer treatment and involved the use of a questionnaire and venous blood collection for the detection of anti-Trypanosoma cruzi antibody.
RESULTS:: The study found a 5% prevalence of patient seropositivity. Significant variables are presented and discussed in the article.
CONCLUSIONS:: Serological T. cruzi checks are recommended in cancer patients, especially individuals from endemic areas in Brazil and other Latin American countries.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app